A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy

Although messenger ribonucleic acid vaccines are substantially effective toward SARS-CoV-2 infection, patients with hematologic malignancies are still prone to the virus. Herein, we report a fatal case of breakthrough SARS-CoV-2 Delta variant infection in a patient with mucosa-associated lymphoid ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamegai, Kohei, Iwamoto, Noriko, Togano, Tomiteru, Maeda, Kenji, Takamatsu, Yuki, Miyazato, Yusuke, Ishikane, Masahiro, Mizokami, Masashi, Sugiyama, Masaya, Iida, Shun, Miyamoto, Sho, Suzuki, Tadaki, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054701/
https://www.ncbi.nlm.nih.gov/pubmed/35500795
http://dx.doi.org/10.1016/j.ijid.2022.04.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054701/
https://www.ncbi.nlm.nih.gov/pubmed/35500795
http://dx.doi.org/10.1016/j.ijid.2022.04.058

Ejemplares similares